In support of Moisture Associated Skin Damage (MASD) Awareness Day, our Clinical Specialist for skin, Georgina Saviolaki, shares an educational background on one of the most common MASD conditions: Incontinence Associated Dermatitis or IAD.
Today is the inaugural Moisture Associated Skin Damage (MASD) Awareness Day. There are local and national drivers to improve patient care and prevent skin damage as a result of moisture associated conditions. [1,2]
MASD is a skin condition caused by overexposure of human skin to irritants such as urine, stool, perspiration, saliva, intestinal liquids from stomas and exudate from wounds. Patient groups that are affected by MASD include those with complex health needs and reduced mobility, multiple comorbidities, or receiving cancer therapies.
Exposure to irritants lead to compromised skin integrity and reduced barrier function, making the skin more permeable and susceptible to damage. The global prevalence of MASD is not accurately reported, with great variability between clinical settings and geographical locations.[6,7,8] Patients affected by MASD can experience pain, burning and pruritus, discomfort and odour, which impact their quality of life.[5,6] Secondary infections can also develop, caused by fungi or bacteria, when the damaged skin is eroded.
Incontinence-associated dermatitis (IAD): Skin damage due to contact between the skin and urine and/or faeces.
Intertriginous dermatitis: Skin damage due to sweat trapped in skin folds in areas with minimal air circulation .
Peri-wound moisture-associated dermatitis: Skin maceration and breakdown caused by excessive wound exudate.
Peristomal moisture-associated dermatitis: Skin damage due to interaction between the skin and stoma secretions.[3,9]
IAD is the most recognised form of MASD with variable incidence and prevalence rates due to a lack of consistent reporting, resulting in the Global IAD Expert Panel publishing best practice principles.
IAD is skin damage due to skin exposure to urine and/or stools. Parameters of IAD include: [3,10]
History: Urinary and /or faecal incontinence
Symptoms: Pain, burning, itching, tingling
Location: Perineum, perigenital, peristomal area, buttocks, gluteal fold, medial and posterior aspects of upper thighs, lower back
Shape/edges: Diffuse infected area with poorly defined edges/may be blotchy
Depth: Intact skin with erythema
Other: Secondary superficial infection might be present
The different stages of IAD include:
|Healthy|| - No redness, intact skin |
- No signs of IAD
|Mild|| - Red but skin intact |
- Erythema, +/- oedema
|Moderate-severe|| - Red with skin breakdown |
- Erythema, +/- oedema
- +/-vesicles/bullae, skin erosion
- +/-denudation of skin
- +/-skin infection
Evidence suggests a link between IAD and other skin conditions such as cutaneous infection and pressure ulcers.[11,12] According to IAD Expert panel, adopting a holistic, integrated approach, focused on prevention strategies and the importance of skin integrity is essential. Early recognition of patients at risk is important, along with training and education of both caregivers and patients.[1,10]
Evidence from the Global IAD Expert Panel suggest two key interventions for the effective prevention of IAD:
Cleansers should be pH neutral. Non-rinse is preferred as prevents additional friction and addition of surfactant is preferred as it reduces surface tension and removes soil and debris from the skin with minimum force. Soap and water are not preferred as alkaline soap alters skin’s pH and damages skin barrier. Skin cleansers increase the likelihood of IAD healing by approximately 50%.
Skin protectants form a barrier between the skin and the moisture or irritants such as urine and/or faeces. When IAD is present, protectants allow the skin barrier to recover and maintain hydration and trans-epidermal water loss.
Is an additional step to support and maintain skin barrier function using leave-on products (moisturisers). They reduce dryness and aid overall health of the skin. Evidence showed that twice daily application of moisturiser, reduced the incidence of skin tears by 50%, in care home patients.
A 3 in 1 pre-moistened wipe, incorporating cleansing, moisturising and protective functions has shown to be an effective intervention to prevent IAD in comparison to soap and water.[16,17]
Cleanse: Cloths are wiped on the skin, which lifts and removes any dirt/external matter from the skin surface. Its chemical formula contains water and a range of surfactants that cleanse the skin.
Protect: as it contains liquid paraffin (6%) and dimethicone (4%), which act as a protective barrier reducing moisture loss from the skin whilst also protecting it from external damage.
Soothe: as Contiplan is rich in emollients, which make up 11.2% of the overall formulation.
Contiplan showed to offer positive barrier function by reducing transepidermal water loss (TEWL) and erythema.
If you'd like more information, head to our Contiplan page. Help raise awareness about Moisture Associated Skin Damage (MASD) by sharing this article on social media.
Clinical Specialist - Skin
We share the latest information about monkeypox virus and discuss…
Clinical Specialist for Consumables, Michael Sanni, shares his hi…
Our Clinical Specialist for Skin, summarises the key points from …
GAMA's Clinical & Scientific Director, Dr. Phil Norville and Clin…